focus -WSS

focus

author：fashion 2025-09-30 17:44:19 - browse：32168

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： A clever new way to fix Medicaid and graduate medical education

focus

WSS

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

White House launches permanent pandemic office

Abortion clinic in Cancun will cater to Americans

Removing probiotics from the NICU could threaten preemies' health

Review: 'Barbie' will hit you like a shot in the heart

A double vaccine crisis is endangering millions of children

focus

focus

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

A clever new way to fix Medicaid and graduate medical education

BioMarin wins approval for gene therapy to treat hemophilia A

Removing probiotics from the NICU could threaten preemies' health

Medicare proposal to cover medical devices draws a mixed reaction

Diversify hospital leadership teams to protect BIPOC patient health

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

HIPAA doesn't protect reproductive records from prosecutors

State Dept. review finds Biden bears some blame for Afghanistan failures

Organ transplantation is at a crossroads. Major reform is needed

focus

A double vaccine crisis is endangering millions of children

Organ transplantation is at a crossroads. Major reform is needed

White House calls on federal agencies to crack down on AI abuses

Senate panel clears PBM, hopsital reforms

MoonLake credibility takes another hit with mid

White House calls on federal agencies to crack down on AI abuses

hotspot

focus

leisure time

focus